Clinical Trials Logo

Her2-negative Tumor clinical trials

View clinical trials related to Her2-negative Tumor.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03750396 Recruiting - Breast Cancer Clinical Trials

Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer

CLEAR
Start date: August 1, 2018
Phase: Phase 2
Study type: Interventional

Local treatment in addition to endocrine treatment as 1st line for oligo-metastatic ER-positive/HER2-negative breast cancer.